The Antibody Society has partnered with numerous conference organizers, including KNect365, Cambridge Healthtech Institute, Hanson Wade and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees.
Complement-based Drug Development Summit
November 14-16, 2017, Boston, MA
The Complement-based Drug Development Summit is the first industry-dedicated meeting that focuses on the research and development of complement therapeutics, providing safe and effective cures for a range of disease indications. The summit will provide a comprehensive, end-to-end analysis of the research and development process in this space. We’ll discuss clinical trial design, indication selection and target identification, right through to safety profiles and regulation.
Across 3 content-packed days, the field’s thought leaders from Alexion, Ra Pharma, Apellis, GSK, Bioverativ, Alnylam and many more will be sharing their insight and lessons learned.
Society members save 20% on the registration fee! Contact us at email@example.com for the code!
2017 Adaptive Immune Receptor Repertoire Community Meeting
December 3-6, 2017, NIH Fishers Lane Facility and the Rockville Hilton, Rockville, MD
The Adaptive Immune Receptor Repertoire Community invites you to attend the 2017 Community Meeting!
High-throughput sequence data characterizing antibody/B-cell and T-cell receptor repertoires is being generated at a rapid pace. These adaptive immune receptor repertoires (AIRRs) are critical to the development of vaccines and therapeutic antibodies, and to the evaluation of cancer immunotherapies. A variety of issues have arisen that are specific to this type of data, and AIRR researchers have held one planning meeting and two community meetings of the AIRR initiative to address them. Working Groups were organized to develop recommendations for:
1) a common repository for AIRR sequence data,
2) minimal standards for publishing or depositing AIRR sequence data, and
3) resources and guidelines for the evaluation of molecular and statistical methods for AIRR sequence data.
These Working Groups have continued to meet since the 2015 Community Meeting and have made significant progress, including proposing standards for the Community in 2017.
During the upcoming 2017 meeting, the first day (Sunday December 3), and the final day (Wednesday December 6) will focus on the organization of the AIRR Community, reports from the Working Groups, and decisions on protocols and standards. On Monday December 4 and Tuesday December 5, we will emphasize scientific presentations and discussions on the use and importance of AIRR-Seq data.
The agenda and information about registration, posters, tool demonstrations, accommodations and meals can be downloaded here. Registration fees for the off-site portion of the meeting are $125 US for trainees and $250 US for all other participants. The number of registrants is limited by the available space, so please register as soon as possible.
Questions? Please contact Felix Breden at firstname.lastname@example.org
Computational Drug Development for Biologics Summit
December 5-7, 2017, Boston, MA
Biologics have increased in prevalence and value in the global marketplace and have continued to become more complex, both by modality and by delivery. The potential for computational tools to add tangible value to the development of biologics is huge, yet this potential remains largely untapped.
The CDD for Biologics Summit is dedicated to harnessing the power of in silico tools, to de-risk drug development from early drug discovery through to late preclinical development. Building upon the framework and success of its inaugural meeting, we will once again gather computational thought leaders in pharma, academia and software providers along with the end-users in computational and structural biology to debate how best to add immediate value to biologics pipelines.
Through sharing novel insights from our industry leading faculty, we will explore how best to add immediate value to biologics pipelines. Discuss how to improve predictability of target ID and validation, understand protein/protein interactions, enhance rational candidate selection, and optimize developability characteristics.
View the speaker line-up or find out more here.
Antibody Society members are eligible for a special 20% discount. Contact us at email@example.com for the code!
Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society
December 11-15, 2017 at the Manchester Grand Hyatt San Diego in San Diego, CA
Join us for our 10th anniversary celebration!
Founded in 2007, the Society is celebrating its 10-year anniversary at the Antibody Engineering & Therapeutics conference and exhibition, our premier forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation binders. For over 25 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs.
Session information can be found here. Please register on the KNect365 web site.
We look forward to seeing you there!
Society members save 15% on the registration fee – Contact us at firstname.lastname@example.org for the code!
Immunotherapies for Infectious Diseases Congress 2017 (I4ID2017)
December 11-12, 2017, Lyon – France, The Lyon Congress Center
The 1st Immunotherapies for Infectious Diseases Congress 2017 (I4ID2017), organized by MabDesign and BIOASTER will bring together pharmaceutical industries, research labs, clinicians, service providers, technology developers and policy makers to exchange about the development of immunotherapy solutions for prevention and treatment of infectious diseases.
The Scientific Committee has set up an exciting program for the I4ID 2017 Congress, focusing on antibodies as immunotherapies for infectious diseases that includes keynote lectures, pitch talks of new creative projects, and industrial talks from big pharmaceutical companies. The I4ID 2017 Congress program also contains several opportunities for networking and dedicated time for business partnering.
The topics covered during this meeting are:
– Immunotherapy against viral infections
– Immunotherapy as alternative treatment to antibiotics
– Immunotherapy against emergent or re-emergent and bioterrorism agents
– Next-Generation Immunotherapy against Infectious Diseases
– Cross-talk: Accelerate the development & bioproduction for affordable immunotherapies solutions
CALL FOR ABSTRACTS – Deadline 15th September 2017
You work in the field of infectious diseases and you have an innovation to share concerning diagnostics or immunotherapies?
You’re part of a SME / start-up / research laboratory? You want to share your expertise?
Share your innovative products, new technologies and research projects at the Pitch Session “Scientific and technological Innovation in Diagnostics and Immunotherapies for infectious diseases” or during the Poster session! Check the guidelines to submit your abstract: http://www.i4id.org/abstracts.php
This is a great opportunity for start-ups, SMEs, and academic laboratories to share their new work!
Early Bird Registration until Friday, 15th September 2017 – register early to secure the best rates!
Register now: http://www.i4id.org/register.php
For more details on the program and to register please visit the website: http://www.i4id.org
PepTalk: The Protein Science Week
January 8-12, 2018, San Diego, CA
PepTalk: The Protein Science Week is one of the largest annual gatherings of protein science researchers in the world. Now, in its 17th year, PepTalk attracts nearly 1,300 experts from academia, biotech and pharma who come together for one week of intensive learning and networking to discover new opportunities, apply alternative solutions, and develop promising partnerships.
This event covers a wide spectrum of applied protein sciences with emphasis on upstream R&D engineering to downstream biologics production. And, whether you’re a world-renowned researcher or a current graduate student, PepTalk has something to offer. Learn more at www.CHI-PepTalk.com
Society members save 20% on the registration fee!
Join Us for the 2018 Keystone Symposia conference on:
Scientific Organizers: Paul W. H. I. Parren and Erica Ollmann Saphire
Abstract Deadline: November 21, 2017
Discounted Registration Deadline: December 19, 2017
The approval of Besponsa and re-approval of Mylotarg has injected huge excitement into the ADC field. Now with 4 approved drugs, over 65 candidates in clinical development and many more in preclinical development, ADCs are rapidly living up to their name – “magic bullets”.
Yet the narrow therapeutic index of ADCs means developing a clinically effective ADC is not without challenges. There are more ADCs in clinical development than ever, continuous innovation in ADC technology and rapid advances in manufacturing processes readying for commercialisation. All this means there is a lot to be distilled at World ADC Berlin 2018.
Now in it’s 8th year, World ADC Berlin is Europe’s leading antibody-drug conjugate conference. Across three days, this comprehensive three-streamed programme will cover every element of ADCs from discovery, development, manufacturing and clinical.
This is the forum ADC drug developers converge at for three days to immerse themselves in the latest ADC science to enable the development of more clinically safe and efficacious ADCs.
Society members receive a 10% discount after 12 January and a 20% discount after 9 February !